/

atavistik-bio

Develops precision allosteric small molecule therapeutics.

BiotechnologyBiopharmaceuticals atavistikbio.com ↗

Company facts

Founded: 2021
Employees: 37
Headquarters: United States
Type: Private
Funding: Series B · $160M · 2026